S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

Realaus laiko atnaujinimai Cryosite Ltd [CTE.AX]

Birža: ASX Pramonė: Pharmaceuticals, Biotechnology & Life Sciences
Atnaujinta3 geg. 2024 @ 08:59

-3.53% $ 0.820

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 08:59):
Profile picture for Cryosite Ltd

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage...

Stats
Šios dienos apimtis 1.03M
Vidutinė apimtis 22 706.00
Rinkos kapitalizacija 40.02M
EPS $0 ( 2024-02-23 )
Last Dividend $0.0150 ( 2023-09-07 )
Next Dividend $0 ( N/A )
P/E 27.33
ATR14 $0 (0.00%)

Cryosite Ltd Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Cryosite Ltd Finansinės ataskaitos

Annual 2023
Pajamos: $11.94M
Bruto pelnas: $6.48M (54.28 %)
EPS: $0.0289
FY 2023
Pajamos: $11.94M
Bruto pelnas: $6.48M (54.28 %)
EPS: $0.0289
FY 2022
Pajamos: $11.76M
Bruto pelnas: $6.27M (53.36 %)
EPS: $0.0279
FY 2021
Pajamos: $10.02M
Bruto pelnas: $5.89M (58.80 %)
EPS: $0.0139

Financial Reports:

No articles found.

Cryosite Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0100
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0.0150
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Cryosite Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.33 - Stable (6.61%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.00500 2012-03-16
Last Dividend $0.0150 2023-09-07
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 13 --
Total Paid Out $0.0900 --
Avg. Dividend % Per Year 0.00% --
Score 3.12 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.33
Div. Directional Score 8.29 --
Next Divdend (Est)
(2024-11-11)
$0.0175 Estimate 3.17 %
Dividend Stability
0.25 Very Poor
Dividend Score
3.12
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
QVE.AX Ex Dividend Knight 2023-08-15 Quarterly 0 0.00%
BFG.AX Ex Dividend Junior 2023-08-30 Semi-Annually 0 0.00%
JLG.AX Ex Dividend Junior 2023-09-01 Annually 0 0.00%
SNC.AX Ex Dividend Knight 2023-05-16 Semi-Annually 0 0.00%
CKF.AX Ex Dividend Knight 2023-07-10 Semi-Annually 0 0.00%
MPL.AX Ex Dividend Knight 2023-09-13 Semi-Annually 0 0.00%
VG1.AX No Dividend Player 2023-08-23 Sporadic 0 0.00%
DTL.AX Ex Dividend Knight 2023-09-14 Semi-Annually 0 0.00%
ORG.AX Ex Dividend Knight 2023-09-05 Semi-Annually 0 0.00%
AGL.AX Ex Dividend Knight 2023-08-23 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1251.5007.5010.00[0 - 0.5]
returnOnAssetsTTM0.07111.2007.639.16[0 - 0.3]
returnOnEquityTTM0.5551.5004.947.41[0.1 - 1]
payoutRatioTTM0.464-1.0005.36-5.36[0 - 1]
currentRatioTTM2.030.8004.853.88[1 - 3]
quickRatioTTM1.9420.8003.282.63[0.8 - 2.5]
cashRatioTTM1.4581.5003.014.51[0.2 - 2]
debtRatioTTM0.114-1.5008.10-10.00[0 - 0.6]
interestCoverageTTM15.391.0005.415.41[3 - 30]
operatingCashFlowPerShareTTM0.04932.009.9810.00[0 - 30]
freeCashFlowPerShareTTM0.04052.009.9810.00[0 - 20]
debtEquityRatioTTM0.873-1.5006.51-9.76[0 - 2.5]
grossProfitMarginTTM0.5501.0004.174.17[0.2 - 0.8]
operatingProfitMarginTTM0.1381.0009.239.23[0.1 - 0.6]
cashFlowToDebtRatioTTM0.9521.0005.825.82[0.2 - 2]
assetTurnoverTTM0.5690.8009.547.63[0.5 - 2]
Total Score11.25

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM25.391.0007.540[1 - 100]
returnOnEquityTTM0.5552.506.757.41[0.1 - 1.5]
freeCashFlowPerShareTTM0.04052.009.9910.00[0 - 30]
dividendYielPercentageTTM7.931.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.04932.009.9810.00[0 - 30]
payoutRatioTTM0.4641.5005.36-5.36[0 - 1]
pegRatioTTM-0.5081.500-6.720[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1911.0007.730[0.1 - 0.5]
Total Score5.33

Cryosite Ltd

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and research and pharmaceutical industry. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.